文献速递复苏、休克与脓毒症中毒与环境急症

成人药物过量相关院外心脏骤停的表现与结局

Presentation and Outcomes of Adults With Overdose-Related Out-of-Hospital Cardiac Arrest.
PubMed 文献 · JAMA Netw Open · 2023-11-01
一句话结论2015—2021年美国金县药物过量相关院外心脏骤停发病率从5.2升至13.0/10万人年,阿片+兴奋剂联合中毒者出院存活率最低(10%)。

该基于美国金县2015年1月1日至2021年12月31日的队列研究纳入6790例成人急诊医疗服务治疗的院外心脏骤停(OHCA),其中药物过量相关OHCA(OD-OHCA)702例、非药物过量OHCA 6088例。OD-OHCA发病率从2015年5.2/10万人年升至2021年13.0/10万人年(趋势P<.001),非OD-OHCA无显著时间变化(P=.30)。OD-OHCA更常无人目击(66% vs 41%)、可除颤心律更少(8% vs 25%),未校正存活率无差异(20% vs 18%)。按药物谱分层,阿片+兴奋剂联合者出院存活率最低(10%),且多因素校正后差异持续存在。

要点

  • OD-OHCA发病率7年间从5.2/10万人年升至13.0/10万人年(趋势P<.001),非OD-OHCA无显著变化(P=.30)。
  • OD-OHCA以无人目击(66% vs 41%)和不可除颤心律(可除颤仅8% vs 25%)为主,需警惕非典型复苏路径。
  • 未校正出院存活率OD-OHCA 20%(138/702)与非OD-OHCA 18%(1095/6088)无差异。
  • 单纯兴奋剂OHCA可除颤心律比例(24%,31/129)高于单纯阿片(4%,11/295)和联合组(5%,10/205)。
  • 联合阿片-兴奋剂OHCA出院存活率最低(10%,21/205),低于单纯兴奋剂(22%,29/129)和其他药物(26%,19/73),多因素校正后仍持续。

适用人群与场景

  • 美国金县2015年1月1日至2021年12月31日急诊医疗服务治疗的成人OHCA患者,共6790例,其中OD-OHCA 702例、非OD-OHCA 6088例。
  • OD-OHCA按药物谱分为:单纯阿片无兴奋剂、单纯兴奋剂无阿片、阿片与兴奋剂联合、其他非兴奋剂非阿片药物四类。

诊断标准与关键阈值

  • OHCA病因通过急诊医疗服务、医院和法医记录判定,分为非OD-OHCA或OD-OHCA。
  • 良好功能状态定义为出院时脑功能分类(Cerebral Performance Category)1或2级。

红旗征与不能漏的情况

  • OD-OHCA更常为无人目击(66% [460/702] vs 非OD 41% [2515/6088]),可除颤心律更少(8% [56/702] vs 25% [1529/6088])。

研究设计与关键结果

  • 队列研究,美国金县单系统6790例急诊医疗服务治疗的成人OHCA;OD-OHCA 702例(中位年龄41岁[IQR 29-53],男性64%[450例]、女性36%[252例]),非OD-OHCA 6088例(中位年龄66岁[IQR 56-77],男性65%[3944例]、女性35%[2144例])。
  • OD-OHCA发病率从2015年5.2(95%CI 3.8-6.6)/10万人年升至2021年13.0(95%CI 10.9-15.1)/10万人年(趋势P<.001);非OD-OHCA发病率无显著时间变化(P=.30)。
  • 未校正出院存活率OD-OHCA 20%(138/702)vs 非OD-OHCA 18%(1095/6088),无差异。
  • 单纯兴奋剂OHCA可除颤心律24%(31/129),高于单纯阿片4%(11/295)和联合阿片-兴奋剂5%(10/205)。
  • 单纯兴奋剂OHCA有人目击50%(64/129),高于其他药物19%(14/73)和联合阿片-兴奋剂23%(48/205)。
  • 联合阿片-兴奋剂OHCA出院存活率最低10%(21/205),低于单纯兴奋剂22%(29/129)和其他药物26%(19/73),多因素校正后差异持续存在。

证据类型、等级与局限

  • 证据类型:队列研究(基于人群的队列研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • OD-OHCA发病率上升且以无人目击、不可除颤心律为主,提示复苏团队应针对药物中毒性骤停的特点调整评估与处置。
  • 联合阿片-兴奋剂OHCA出院存活率最低(10%),作者认为这一发病率上升与存活率低的组合支持考虑药物特异性谱的预防和治疗举措。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Drug overdose (OD) is a public health challenge and an important cause of out-of-hospital cardiac arrest (OHCA). Existing studies evaluating OD-related OHCA (OD-OHCA) either aggregate all drugs or focus on opioids. The epidemiology, presentation, and outcomes of drug-specific OHCA are largely unknown.

OBJECTIVE: To evaluate the temporal pattern, clinical presentation, care, and outcomes of adult patients with OHCA overall and according to the drug-specific profile.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study of adults with OHCA in King County Washington was conducted between January 1, 2015, and December 31, 2021. Etiology of OHCA was determined using emergency medical service, hospital, and medical examiner records. Etiology was classified as non-OD OHCA or OD-OHCA, with drug-specific profiles categorized as (1) opioid without stimulant, (2) stimulant without opioid, (3) opioid and stimulant, or (4) all other nonstimulant, nonopioid drugs. Statistical analysis was performed on July 1, 2023.

EXPOSURE: Out-of-hospital cardiac arrest.

MAIN OUTCOMES AND MEASURES: The primary outcome was survival to hospital discharge. The secondary outcome was survival with favorable functional status defined by Cerebral Performance Category 1 or 2 based on review of the hospital record.

RESULTS: In this cohort study, there were 6790 adult patients with emergency medical services-treated OHCA from a US metropolitan system. During the 7-year study period, there were 702 patients with OD-OHCA (median age, 41 years [IQR, 29-53 years]; 64% male [n = 450] and 36% female [n = 252]) and 6088 patients with non-OD OHCA (median age, 66 years [IQR, 56-77 years]; 65% male [n = 3944] and 35% female [n = 2144]). The incidence of OD-OHCA increased from 5.2 (95% CI, 3.8-6.6) per 100 000 person-years in 2015 to 13.0 (95% CI, 10.9-15.1) per 100 000 person-years in 2021 (P < .001 for trend), whereas there was no significant temporal change in the incidence of non-OD OHCA (P = .30). OD-OHCA were more likely to be unwitnessed (66% [460 of 702] vs 41% [2515 of 6088]) and less likely to be shockable (8% [56 of 702] vs 25% [1529 of 6088]) compared with non-OD OHCA. Unadjusted survival was not different (20% [138 of 702] for OD vs 18% [1095 of 6088] for non-OD). When stratified by drug profile, combined opioid-stimulant OHCA demonstrated the greatest relative increase in incidence. Presentation and outcomes differed by drug profile. Patients with stimulant-only OHCA were more likely to have a shockable rhythm (24% [31 of 129]) compared with patients with opioid-only OHCA (4% [11 of 295]) or patients with combined stimulant-opioid OHCA 5% [10 of 205]), and they were more likely to have a witnessed arrest (50% [64 of 129]) compared with patients with OHCA due to other drugs (19% [14 of 73]) or patients with combined stimulant-opioid OHCA (23% [48 of 205]). Patients with a combined opioid-stimulant OHCA had the lowest survival to hospital discharge (10% [21 of 205]) compared with patients with stimulant-only OHCA (22% [29 of 129]) or patients with OHCA due to other drugs (26% [19 of 73]), a difference that persisted after multivariable adjustment.

CONCLUSIONS AND RELEVANCE: In a population-based cohort study, the incidence of OD-OHCA increased significantly from 2015 to 2021, with the greatest increase observed among patients with a combined stimulant-opioid OHCA. Presentation and outcome differed according to the drug-specific profile. The combination of increasing incidence and lower survival among among patients with a opioid-stimulant OHCA supports prevention and treatment initiatives that consider the drug-specific profile.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Yogeswaran V, Drucker C, Kume K, et al. Presentation and Outcomes of Adults With Overdose-Related Out-of-Hospital Cardiac Arrest. JAMA Netw Open. 2023. PMID: 37934498. doi:10.1001/jamanetworkopen.2023.41921

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。